Is it Time to Dump Reviva Pharmaceuticals Holdings, Inc. (RVPH) Stock After it Has Risen 33.93% in a Week?

Overall market sentiment has been high on Reviva Pharmaceuticals Holdings, Inc. (RVPH) stock lately. RVPH receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Reviva Pharmaceuticals Holdings, Inc. has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on RVPH!

See Full RVPH Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With RVPH Stock Today?

Reviva Pharmaceuticals Holdings, Inc. (RVPH) stock is lower by -2.22% while the S&P 500 has risen 0.29% as of 10:15 AM on Wednesday, Mar 27. RVPH is down -$0.09 from the previous closing price of $3.83 on volume of 275,357 shares. Over the past year the S&P 500 has gained 31.21% while RVPH is down -10.07%. RVPH lost -$1.67 per share in the over the last 12 months. To screen for more stocks like Reviva Pharmaceuticals Holdings, Inc. click here.

More About Reviva Pharmaceuticals Holdings, Inc.

Reviva Pharmaceuticals Holdings Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of internally discovered therapies that address unmet medical needs in the areas of central nervous system, respiratory, and metabolic diseases. The company is currently focused on the development of its lead product candidate, RP5063, which targets schizophrenia, bipolar disorder, major depressive disorder, behavioral & psychotic symptoms, dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, and also respiratory indications such as pulmonary arterial hypertension & idiopathic pulmonary fibrosis. Click Here to get the full Stock Report for Reviva Pharmaceuticals Holdings, Inc. stock.